Literature DB >> 10999615

Endotoxemia and mediator release during cardiac surgery.

E Boelke1, M Storck, K Buttenschoen, D Berger, A Hannekum.   

Abstract

Endotoxemia in man is a controversial issue. However, endotoxin is a potent trigger of the inflammatory response. Therefore, endotoxin translocation and mediator release was investigated in patients undergoing cardiac surgery. In 40 patients (13 women and 27 men, ages ranging from 30 to 73 years with a median of 60 years), plasma concentrations of endotoxin, interleukin-6 (IL-6), and C-reactive protein (CRP) were determined during and after cardiovascular bypass. In a subgroup of 10 patients, myeloid-related proteins: MRP8, MRP14, and the soluble heterocomplex (MRP8/MRP14) levels were additionally studied. A significant increase (p < 0.01) of plasma endotoxin concentrations was found during surgery, culminating in a peak (median value of 0.82 EU/mL) during reperfusion. Plasma levels of endotoxin continued to be slightly raised until the 5th postoperative day, whereas those of interleukin-6 rose at the end of the operation and were at their highest level 6 hours postoperatively (median value of 218 pg/mL). CRP levels were increased 24 hours postoperatively with a median value of 114 mg/L and peaked on day 2 (191 mg/L). A statistically significant correlation between the intraoperative endotoxin plasma concentrations and IL-6 concentrations was established (p < 0.05). The MRP8/MRP14 heterocomplex increased until day 2 after surgery, except MRP14, which showed the highest level at day 1 (55 ng/mL). Cardiac surgery is associated with endotoxemia and a marked acute-phase response. Therefore, endotoxin must be regarded as a pathophysiologic mediator. The role of the gut as a source of endotoxemia following cardiac surgery deserves further attention.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999615     DOI: 10.1177/000331970005100906

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  9 in total

1.  Investigating the Impacts of Preoperative Steroid Treatment on Tumor Necrosis Factor-Alpha and Duration of Extubation Time underwent Ventricular Septal Defect Surgery.

Authors:  H Hakan Poyrazoğlu; Zeynel Duman; Şerafettin Demir; M Kemal Avşar; Atakan Atalay; Bahattin Çiftçi; İhsan Bayraktar; Funda Tor
Journal:  Balkan Med J       Date:  2016-03-01       Impact factor: 2.021

2.  Relationship of granulocyte colony stimulating factor with other acute phase reactants in man.

Authors:  M Noursadeghi; M B Pepys; R Gallimore; J Cohen
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

3.  Prevalence of endotoxemia after surgery and its association with ICU length of stay.

Authors:  Franco Valenza; Lorella Fagnani; Silvia Coppola; Sara Froio; Francesca Sacconi; Cecilia Tedesco; Micol Maffioletti; Marta Pizzocri; Valentina Salice; Maria Luisa Ranzi; Cristina Marenghi; Luciano Gattinoni
Journal:  Crit Care       Date:  2009-06-29       Impact factor: 9.097

4.  Pharmacodynamic evaluation of the neutralization of endotoxin by PMX622 in mice.

Authors:  Philip Lake; Jeffrey DeLeo; Franklin Cerasoli; Lennart Logdberg; Marla Weetall; Dean Handley
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

5.  Influence of modest endotoxemia on postoperative antithrombin deficiency and circulating secretory immunoglobulin a levels.

Authors:  Tetsuji Fujita; Takashi Imai; Sadao Anazawa
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

6.  Alkaline Phosphatase in Infant Cardiopulmonary Bypass: Kinetics and Relationship to Organ Injury and Major Cardiovascular Events.

Authors:  Jesse A Davidson; Tracy T Urban; Christine Baird; Suhong Tong; Alan Woodruff; Mark Twite; James Jaggers; Eric A F Simões; Paul Wischmeyer
Journal:  J Pediatr       Date:  2017-11       Impact factor: 4.406

7.  Endotoxemia related to cardiopulmonary bypass is associated with increased risk of infection after cardiac surgery: a prospective observational study.

Authors:  David J Klein; Francoise Briet; Rosane Nisenbaum; Alexander D Romaschin; C David Mazer
Journal:  Crit Care       Date:  2011-02-23       Impact factor: 9.097

Review 8.  The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?

Authors:  Benedict C Creagh-Brown; Gregory J Quinlan; Timothy W Evans; Anne Burke-Gaffney
Journal:  Intensive Care Med       Date:  2010-07-15       Impact factor: 17.440

9.  High levels of S100A8/A9 proteins aggravate ventilator-induced lung injury via TLR4 signaling.

Authors:  Maria T Kuipers; Thomas Vogl; Hamid Aslami; Geartsje Jongsma; Elske van den Berg; Alexander P J Vlaar; Joris J T H Roelofs; Nicole P Juffermans; Marcus J Schultz; Tom van der Poll; Johannes Roth; Catharina W Wieland
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.